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Background  
In March 2017 a cattle farmer spread manure across his farmland. The 
Environment Agency subsequently took a soil sample from the plot of land. 
Following an analysis by the Netherlands Forensic Institute (NFI) the soil sample 
was found to contain MDMA. In October 2017 the Netherlands Food and Consumer 
Product Safety Authority (NVWA) took samples of the maize that was growing on 
the plot of land. An analysis performed by RIKILT Wageningen University & 
Research found that these nine samples also contained MDMA.  
 
These findings prompted the directorate Enforcement of NVWA to seek advice 
from the Office for Risk Assessment & Research (BuRO) on the risks of the 
consumption of MDMA-contaminated maize to public and animal health.  
 
The following questions were addressed to BuRO:  
1. What are the risks to animal health if the MDMA in the maize plant is fed 
to farm animals either in maize silage (whole plant with cob) or maize  
grain (cobs)?  
2. What are the public health risks if consumers eat meat or drink milk from 
farm animals fed with MDMA-contaminated maize (see question 1)?  
3. What are the public health risks if consumers consume MDMA-
contaminated maize (cobs)?  
4. How should the NVWA deal with any other substances (used or released in 
the synthesis of MDMA) that may be present in maize?  
5. How should the NVWA deal with MDMA and any other substances (used or 
released in the synthesis of MDMA) that may be present in the soil and 
surface water?  
 
Approach  
BuRO performed a search of relevant literature in Google, Google Scholar and 
PubMed using combinations of the key words 'MDMA', 'synthesis' and 'toxicity'.  
 
In addition, BuRO consulted the available MDMA expertise at the Dutch Health and 
Youth Care Inspectorate (IGJ) and the Netherlands Forensic Institute (NFI). As an 
additional source of information BuRO used  the report 'Assessment of 3,4-
methylenedioxy-N-methamphetamine (MDMA) in maize' published by the RIVM 
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and RIKILT Front Office for Food and Product Safety in December 2015 (report no. 
V/090130, Appendix 1).  
 
Finally, BuRO requested the RIVM-RIKILT Front Office for Food and Product Safety 
to conduct further research based on the above questions and the following three 
additional questions (see Appendix 2):   
 
1. Has new literature become available, since the risk assessment issued by 
the Front Office in 2015, on the toxicity of MDMA, which provides greater 
insight into a possible 'safe' limit value for both humans and animals?   
2. What uncertainties are there in the risk assessment process?  
3. What other substances used or released in the synthesis of MDMA are 
expected to be found in chemical waste from drug production and in what 
concentrations?  
 
Findings  
In 2015 the RIVM-RIKILT Front Office for Food and Product Safety derived two 
health-based guidance values for the short-term and long-term exposure of 
humans to MDMA, namely an ADI1 of 8.3 μg/kg body weight per day for short-
term exposure and an ADI of 12.5 μg/kg body weight per day for long-term 
exposure.  
 
An ADI of 125 μg/kg body weight per day has been derived for the exposure of 
animals to MDMA.  
 
Three of the nine samples of maize silage contained a concentration of MDMA 
ranging between 12 and 17 μg/kg. None of the maize grain samples contained a 
concentration of MDMA higher than 10 μg/kg.  
 
The maximum estimated intake for farm animals after the consumption of MDMA-
contaminated maize is 1.2 μg/kg body weight per day (broiler chickens and laying 
hens). This intake is a factor of 100 lower than the (animal) ADI of 125 μg/kg 
body weight. The intake for other animal species is lower than for poultry. It can 
therefore be concluded that the concentrations of MDMA found are not expected 
to pose any health risks to farm animals if the maize plant is fed to farm animals 
either as silage maize (whole plant with cob) or grain maize (cobs).  
 
The maximum estimated exposure of consumers to MDMA through the 
consumption of meat, milk and eggs from animals that have eaten MDMA-
contaminated maize (indirect exposure) is 3.76 μg/kg body weight per day. The 
maximum estimated exposure of consumers to MDMA through the direct 
consumption of contaminated maize is 0.007 μg/kg body weight per day (60-kg 
adult) or 0.022 μg/kg body weight per day (20-kg child). Both the indirect 
exposure of adults and the direct exposure of adults and/or children is under the 
health-based guidance value for short-term exposure (8.3 μg/kg body weight per 
day). It can therefore be concluded that there are no public health risks if 
consumers consume meat or milk derived from farm animals that have been fed 
with MDMA-contaminated maize.  
 
The estimated exposure described above contains uncertainties, which in most 
cases may lead to an overestimation, but occasionally to an underestimation of 
the actual exposure. The calculations made are so conservative that the 
 
1 This ADI has been derived for acute effects and it should therefore be regarded more as a 
reference dose (ARfD) rather than a health limit value for long-term exposure.  
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uncertainties have no impact on the conclusion drawn that the concentrations of 
MDMA measured in maize do not pose risks to humans and animals.  
 
Various methods can be used to synthetise MDMA. Chemical waste from drug 
production can contain some MDMA in addition to various solvents, converted 
reagents and by-products.  
 
At present, no information is available on the substances that could be present in 
the maize samples and their concentration levels. These samples must be 
analysed for this purpose.   
 
MDMA and the substances stated above could enter the environment (soil and 
surface water). To that end, the NVWA might want to contact the colleague 
inspector responsible for this area at the Human Environment and Transport 
Inspectorate (ILT).  
 
NVWA-BuRO recommendations   
BuRO concludes that the concentrations of MDMA found in maize do not pose a 
risk to public health. However, there is a risk in terms of the adverse effects on 
the food safety system. The presence of MDMA and possibly other substances 
from the MDMA waste in maize is undesirable.  
 
To the Head of Agency: 
-  Analyse, if there are indications of the production of MDMA, whether the 
residual waste from this process in the vicinity of the food crops grown, the 
maize silage and maize grain samples contain any (residues of) raw 
materials, solvents and (residues of) reagents used in the synthesis of 
MDMA.  
-  Should the analytical results give cause to do so, please notify the 
appropriate authorities of these results.  
 
 
Yours sincerely,  
 
 
 
 
Prof. Antoon Opperhuizen  
Director of the Office for Risk Assessment & Research  
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SUBSTANTIATION  
 
Background  
MDMA (3,4-methylenedioxy-N-methamphetamine) is an amphetamine derivative 
that was patented in the early 20th century either for use as an appetite 
suppressant or as a precursor for therapeutic compounds. The toxicology of MDMA 
was analysed for the first time in the 1950s by the American army. In the 1980s 
MDMA was used during psychotherapy sessions. MDMA was said to increase the 
patient's self-confidence and to facilitate therapeutic communication. In 1985 the 
U.S. Food and Drug Administration (FDA) banned MDMA as a medicine. At the end 
of the 1970s MDMA was illegally launched on the market as Ecstasy. Nowadays 
Ecstasy is used primarily to induce the ability to dance all night non-stop (Green 
et al. 2003; Capela et al. 2009; White 2014).  
 
Synthesis of MDMA  
Various methods can be used to synthetise MDMA. MDP2P (3,4-
methylenedioxyphenyl-2-propanone, also known as piperonyl methyl ketone or 
PMK) is usually used as the precursor. MDP2P is synthetised from piperonal, 
safrole or isosafrole and after reacting with methylamine is converted into MDMA. 
MDP2P can also be converted into MDEA (3,4-Methylenedioxy-N -
ethylamphetamine) using ethylamine and into MDA (3,4-
methyleendioxyamphetamine) using ammonia (Wikipedia2; Shulgin 1991). The 
synthesis route used depends on the availability of raw materials, solvents and 
reagents.  
 
Since MDMA is the desired end product, it is plausible that the chemical waste 
from drug production contains a small quantity of MDMA and many solvents, 
converted reagents and by-products. The usual chemicals for the various synthetic 
routes of MDMA are described in a United Nations Office on Drugs and Crime 
(UNODC) document (UNODC 2011). Appendix 1 to the Front Office's report 
contains a list of raw materials and reagents used for the synthesis of MDMA. If 
the synthesis is executed carefully and efficiently, relatively few raw materials and 
reagents will be present in unchanged form in drug waste. This does not apply to 
solvents, which are in fact expected to occur in higher concentrations in chemical 
waste from drug production.  
 
According to the Front Office, the following chemicals could potentially be found in 
chemical waste from drug production:  
- (Residues of) raw materials: piperonal, piperonyl alcohol, PMK (3,4-
methylenedioxy-phenyl-2-propanone), safrole, isosafrole, MDA (N-
desmethyl MDMA), catechol and furthermore all by-products and 
intermediary products.  
- Solvents: methanol, toluene, benzene, dimethylformamide, formamide, 
dichlormethane, diethyl ether and tetrahydrofuran.  
- (Residues of) reagents: nitroethane, hydrobromide (HBr), hydrochloride 
(HCl), potassium hydroxide (KOH) and lithium, aluminium,zinc, mercury, 
copper and nickel sulphates.  
 
In the Netherlands, MDMA is primarily synthesised from PMK. Depending on the 
step in the production process, the chemical waste from drug production contains 
the following chemicals: (1) water containing methanol or isopropyl alcohol and 
low concentrations of MDMA and PMK/reduced PMK, or (2) a (water) solution of 
 
2 https://en.wikipedia.org/wiki/MDMA#Synthesis Consulted on 16 November 2017.  
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hydrochloric acid containing acetone and low concentrations of MDMA and possibly 
PMK and reduced PMK (NFI 2015). The concentration of MDMA and PMK/reduced 
PMK in drug waste is around 2-10 mg/ml.  
 
Other pollutants found in low concentrations in chemical waste from drug 
production are piperonal, safrole, isosafrole, N-acetyl-MDMA and N-formyl-MDMA, 
various aldol condensation products from acetone and various imines.  
 
Effect of MDMA  
MDMA is rapidly absorbed after oral intake. MDMA hardly attaches to proteins and 
is therefore primarily found in plasma. MDMA is largely metabolised by the liver 
and subsequently excreted in urine. The half-life of MDMA ranges between six and 
nine hours (Capela et al. 2009).  
 
MDMA has an effect on the serotonergic system. Serotonin is a neurotransmitter 
in the brain that is excreted by synaptic vesicles and enables signals to be 
transmitted between the brain cells (neurons). After excretion, serotonin is 
reabsorbed into the synaptic vesicles. MDMA blocks this process to prevent 
serotonin from being reabsorbed and the level of serotonin in the bloodstream 
rises (Green et al. 2003; Capela et al. 2009).  
 
Stimulation of the serotonergic system causes the 'desirable effects' of MDMA to 
occur, due to which a user has a lot of energy, feels happy and has a need to 
connect with others (White 2014). The recommended maximum dose for 
recreational use is 1 mg/kg body weight (Drugsinfoteam.nl). Higher doses 
increase the risk of adverse effects. The risks associated with the use of MDMA 
include anxiety and panic attacks, overheating, water poisoning, brain damage, 
liver and kidney damage and a higher heart rate and blood pressure (White 
2014).  
 
The risks of exposure to MDMA are higher for certain groups, such as young 
people, the mildly intellectually disabled and children whose parents have 
psychological or addiction problems (Front Office 2015).  
 
Health-based limit values  
Humans  
In 2015 the Front Office derived two acceptable daily intake (ADI) values (Front 
Office 2015). The first is based on the fact that an XTC pill contains around 80 mg 
of MDMA and it is plausible that 50 mg of MDMA causes noticeable effects. This 
corresponds to an exposure of 0.83 mg/kg body weight per day for an adult (60 
kg). Taking account of a safety factor of 100 (10 for extrapolating a LOEL to a 
NOEL, and 10 for the variation between people), this results in an ADI of 8.3 
μg/kg body weight per day. This corresponds to 498 μg MDMA per day for a 
60-kg adult. Since this ADI has been derived for acute effects, it should be 
regarded more as an acute reference dose (ARfD) rather than as a health limit 
value for long-term exposure.  
 
The second ADI is based on a study of mice, in which the blood parameters 
indicating liver and kidney damage had risen. The no-observed-adverse-effect 
level (NOAEL) in this case is 1.25 mg/kg body weight per day. Taking account of a 
safety factor of 100 (10 for extrapolating the variation between animals and 
people, and 10 for the variation between people), an ADI can be derived of 
12.5 μg/kg body weight per day. This corresponds to 750 μg MDMA per day 
for a 60-kg adult.  
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Animals  
An ADI can also be derived for animals. Similar to humans, this is based on a 
study of mice, in which the blood parameters indicating liver and kidney damage 
had risen. The NOAEL is 1.25 mg/kg body weight per day. Taking account of a 
safety factor of 10 (for the variation between different animal species), an 
(animal) ADI can be derived of 125 μg/ kg body weight per day. This 
corresponds to 62,500 μg MDMA per day for beef cattle (500 kg), 78,125 μg per 
day for dairy cattle (625 kg), 12,500 μg per day for calves (100 kg) and pigs (100 
kg), 213 μg per day for broiler chickens (1.7 kg), 238 μg per day for laying hens 
(1.9 kg), 56,250 μg per day for horses (450 kg), 9,375 μg per day for sheep (75 
kg) and 5,000 μg per day for lambs (40 kg).  
 
MDMA content measured in maize  
The NVWA took samples of two types of maize on a plot of land on which manure 
had been spread that had been mixed with chemical waste from drug production, 
namely  maize silage (whole plant with cob) and maize grain (cobs). RIKILT 
analysed the samples (table 1).  
 
Table 1. Overview of the concentrations of MDMA measured by RIKILT in maize 
silage and grain on a plot of land on which manure had been spread that had been 
mixed with chemical waste from drug production. 
Maize silage Maize grain 
NVWA no.  MDMA (μg/kg)  NVWA no.  MDMA (μg/kg)  
ST01  15  ST02  0.93  
ST03  3  ST04  1.1  
ST05  17  ST06  0.85  
ST07  12  ST08  1.0  
ST09  7.9  ST10  <10*  
ST11  <10  ST12  <10  
ST13  <10  ST14  <10  
ST17  <10  ST16  <10  
ST19  <10  ST18  <10  
  ST20  <10 
*contained a minute trace of MDMA (<10 μg/kg)  
 
Three of the nine samples of maize silage contained a concentration of MDMA 
exceeding 10 μg/kg, i.e. 12 and 17 μg/kg. None of the maize grain samples 
contained a concentration of MDMA higher than 10 μg/kg.  
 
Exposure to MDMA in maize  
Farm animal exposure  
The Front Office made a calculation of the exposure of various types of farm 
animals to MDMA through the consumption of contaminated maize (table 2). This 
is based on a worst-case scenario, in which the total food consumption per day 
consists of maize silage (except for calves, where the known consumption of 
maize silage was used). In reality the consumption of maize by farm animals is 
lower because they either do not eat maize silage but maize grain, and/or because 
a portion of their feed does not consist of maize but other crops. 
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Table 2. The intake of MDMA through maize consumption in various farm animals  
(based on 17 μg MDMA/kg maize). 
 Body weight 
(kg) (OECD 
2013)  
Feed 
consumption 
(kg/day) 
(OECD 2013)  
MDMA intake 
(μg/kg/lg/day)  
Beef cattle  500 12 0.41 
Dairy cows  625 25 0.68 
Calves (0-3 
months)*  
100 2.72 0.46 
Pigs  100 3 0.51 
Broilers  1.7 0.12 1.2 
Laying hens  1.9 0.13 1.2 
Horse 
(sport/leisure)**  
450 8.1 0.31 
Sheep  75 2.5 0.57 
Lambs  40 1.7 0.72 
* Published in Van Raamsdonk 2007. Feed consumption relates specifically to 
maize silage.  
** Published in Bikker 2009.  
 
The maximum estimated exposure is 1.2 μg/kg body weight per day (broilers and 
laying hens). The exposure for other animal species is lower than for poultry.  
 
Indirect consumer exposure 
The Front Office calculated the indirect exposure of a consumer through the 
consumption of farm animals and related products (table 3). The following 
assumptions were applied to a worst-case scenario:  
• 50% transfer to milk.  
• An average daily milk yield of 30 litres (Van Raamsdonk 2007).  
• Consumption of 1.5 litres of milk per day (Food Basket EC 2005).  
• 50% transfer to eggs.  
• Consumption of 2 eggs (100 g) per day (Food Basket EC 2005).  
• 50% of the amount of MDMA in the feed eaten daily enters the piece of meat 
that is subsequently consumed according to the Food Basket (300 g, Food 
basket EC 2005).  
• Consumption by an individual with 60-kg body weight.  
 
Table 3. Indirect exposure of a consumer exposed to MDMA-contaminated maize 
via farm animal products. 
 Consumer exposure to MDMA (μg/kg lg) 
Beef cattle  1.7 
Meat from dairy cows  3.5 
Calves (0-3 months)  0.39 
Pigs  0.43 
Broilers  0.02 
Meat from laying hens  0.02 
Horses  1.1 
Sheep  0.35 
Lambs  0.24 
Cow's milk  0.18 
Egg  0.04 
Food basket*  3.76 
* 300 grams of meat, 2 eggs and 1.5 litres of milk.  
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The maximum estimated consumer exposure to MDMA through indirect exposure 
was 3.76 μg/kg body weight per day if both the meat, the milk and the eggs had 
been derived from animals that had eaten MDMA-contaminated maize. When 
looking at the consumption of one portion of meat/milk/egg, the maximum 
estimated exposure was 3.5 μg/kg body weight for the consumption of meat from 
a dairy cow.  
 
Human exposure  
All the concentrations of MDMA measured in grain maize were below 10 μg/kg. 
The exact value is not clear and therefore this example calculation assumes that 
the maize grain contained 10 μg/kg of MDMA. According to the Dutch National 
Food Consumption Survey, Dutch people (aged 7-69) eat an average of 44 grams 
of maize per day. The maize contained 0.44 μg of MDMA per portion. This 
produces an intake of 0.007 μg/kg body weight per day for an adult (60 kg) and 
an exposure of 0.022 μg/kg body weight per day for a child (20 kg).  
 
The estimated exposure described above contains uncertainties, which in most 
cases may lead to an overestimation, but occasionally to an underestimation of 
the actual exposure. The calculations made are so conservative that the 
uncertainties have no impact on the final conclusion.  
 
Effects of exposure to MDMA in maize  
Farm animals  
The maximum estimated exposure of farm animals following the consumption of 
MDMA-contaminated maize is 1.2 μg/kg body weight per day for both broilers and 
laying hens. This estimated exposure is a factor of 100 below the (animal) ADI 
derived of 125 μg/kg body weight for animals. The exposure for other animal 
species is lower than for poultry. It can therefore be concluded that the 
concentrations of MDMA found in maize are not expected to pose any health risks 
to farm animals.  
 
Consumers  
The maximum estimated consumer exposure to MDMA through indirect exposure 
is 3.76 μg/kg body weight per day if both the meat, the milk and the eggs had 
come from animals that had eaten MDMA-contaminated maize. This exposure is 
below the health-based guidance value for short-term exposure (8.3 μg/kg body 
weight per day). The consumption of products derived from farm animals that 
have eaten maize contaminated with MDMA in the concentrations found therefore 
does not pose any risks to public health.   
 
The maximum estimated exposure of consumers to MDMA through the direct 
consumption of maize is 0.007 μg/kg body weight per day (60-kg adult) or 0.022 
μg/kg body weight per day (20-kg child). The exposure of both adults and 
children is below the health-based guidance value for short-term exposure (8.3 
μg/kg body weight per day).  
 
Furthermore, it can be stated that the maximum intake of MDMA by a 60-kg adult 
is 498 μg before the health-based guidance value is exceeded. Based on an 
average daily consumption of 44 grams of maize, the permitted amount of MDMA 
in one kilogramme of maize is 11,318 μg of MDMA (11.3 mg/kg). This is a factor 
of 1,000 higher than the concentrations of MDMA actually found in maize. The 
direct consumption of maize contaminated with MDMA based on the 
concentrations found does not pose any risks to public health.  
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Conclusions  
The concentrations of MDMA found are not expected to pose any health risks to 
both farm animals and consumers.  
 
This risk assessment relates entirely to MDMA. It is plausible that the chemical 
waste from drug production contained a minimal amount of MDMA given that 
MDMA is the desired end product. In addition to MDMA, chemical waste from drug 
production could also contain other substances, such as residues of raw materials, 
solvents or residues of reagents that could potentially be harmful to animal and/or 
public health if it enters the food chain.  
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Appendix 1. RIVM-RIKILT Front Office for Food and Product Safety (2015). 
Assessment of 3,4-methylenedioxy-N-methamphetamine (MDMA) in maize. 
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Appendix 2. RIVM-RIKILT Front Office for Food and Product Safety (2017). Risk 
assessment of 3,4-methylenedioxy-N-methamphetamine (MDMA) in maize. 
 
 
